Intellectus Partners, LLC Axsome Therapeutics, Inc. Transaction History

Intellectus Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.0 - $4.15 $20,800 - $43,160	-10,400 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.15 - $3.6 $3,010 - $5,040	1,400 Added 15.56%	10,400 $33,000
Q1 2018 May 15, 2018	BUY	$2.35 - $5.6 $21,150 - $50,400	9,000 New	9,000 $22,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Intellectus Partners, LLC with notifications on news.